Safety and efficacy of anti-PD-1 antibodies in elderly patients with metastatic melanoma

被引：12

作者：

Rai, R. ^{[1
]}

McQuade, J. L. ^{[2
]}

Wang, D. Y. ^{[3
]}

Park, J. J. ^{[4
]}

Nahar, K. ^{[1
]}

Sosman, J. A. ^{[3
]}

Beckermann, K. E. ^{[3
]}

Haydu, L. E. ^{[2
]}

Lo, S. ^{[1
]}

Rubinstein, S. ^{[3
]}

Beckermann, K. E. ^{[3
]}

McKean, M. ^{[2
]}

Matthew, S. ^{[3
]}

Guminski, A. ^{[1
]}

Carlino, M. S. ^{[4
]}

Davies, M. ^{[2
]}

Johnson, D. B. ^{[3
]}

Long, G. V. ^{[1
]}

Menzies, A. M. ^{[1
]}

机构：

[1] Univ Sydney, Melanoma Inst Australia, Med Oncol, Sydney, NSW, Australia

[2] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA

[3] Vanderbilt Univ, Med Hematol Oncol, 221 Kirkland Hall, Nashville, TN 37235 USA

[4] Westmead Hosp, Crown Princess Mary Canc Ctr, Med Oncol, Sydney, NSW, Australia

来源：

ANNALS OF ONCOLOGY | 2016年 / 27卷

关键词：

D O I：

10.1093/annonc/mdw379.8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1113PD

引用

页数：1

共 50 条

[1] SAFETY AND EFFICACY OF ANTI-PD1 ANTIBODIES IN THE ELDERLY POPULATION WITH METASTATIC MELANOMA AT THE CANBERRA HOSPITAL
Randhawa, M.
Rai, R.
Nguyen, B.
Ali, S.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 67 - 67
[2] Safety and Activity of Combined Radiotherapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) with Metastatic Melanoma
Liniker, E.
Kong, B.
Menzies, A. M.
Cooper, A.
Ramanujam, S.
Lo, S.
Kefford, R. F.
Fogarty, G. B.
Guminski, A.
Wang, T. W.
Carlino, M. S.
Hong, A.
Long, G. V.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S664 - S664
[3] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, Vyara
Fessler, Jessica
Bao, Riyue
Chongsuwat, Tara
Zha, Yuanyuan
Alegre, Maria-Luisa
Luke, Jason J.
Gajewski, Thomas F.
SCIENCE, 2018, 359 (6371) : 104 - +
[4] Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, Vyara
Fessler, Jessica
Bao, Riyue
Chongsuwat, Tara
Zha, Yuanyuan
Alegre, Maria-Luisa
Luke, Jason
Gajewski, Thomas
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[5] Patterns of acquired resistance to anti-PD-1 antibodies in patients with metastatic melanoma (MM).
Lee, Jenny H. J.
Cooper, Adam James
Lyle, Megan Kate
Liniker, Elizabeth
Menzies, Alexander M.
Kefford, Richard
Long, Georgina V.
Carlino, Matteo S.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[6] Safety and Activity of Combined Radiation Therapy (RT) and Anti-PD-1 Antibodies (PD-1) in Patients (pts) With Metastatic Melanoma
Liniker, E.
Kong, B.
Menzies, A. M.
Cooper, A. J.
Kefford, R. F.
Fogarty, G. B.
Guminski, A.
Carlino, M. S.
Wang, T. W.
Long, G. V.
Hong, A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E635 - E635
[7] Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
Bender, Carolin
Enk, Alexander
Gutzmer, Ralf
Hassel, Jessica C.
CANCER MEDICINE, 2017, 6 (07): : 1581 - 1586
[8] The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma
Ladwa, Rahul
Atkinson, Victoria
MELANOMA RESEARCH, 2017, 27 (02) : 168 - 170
[9] The efficacy and safety of anti-PD-1 therapy in metastatic sarcomas
Yang, Jilong
CANCER RESEARCH, 2020, 80 (16)
[10] Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma
Liniker, E.
Menzies, A. M.
Kong, B. Y.
Cooper, A.
Ramanujam, S.
Lo, S.
Kefford, R. F.
Fogarty, G. B.
Guminski, A.
Wang, T. W.
Carlino, M. S.
Hong, A.
Long, G. V.
ONCOIMMUNOLOGY, 2016, 5 (09):

← 1 2 3 4 5 →